Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-10

Clinical Trial Update: Vortioxetine add-on Treatment Improves the Symptoms in Patients With Bipolar Depression [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating vortioxetine as an add-on therapy shows improvement in symptoms for patients with bipolar depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vortioxetine (vortioxetine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Bipolar Disorder Depression | Phase 2 | Status: UNKNOWN